Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 90

1.

Genomic and transcriptomic changes complement each other in the pathogenesis of sporadic Burkitt lymphoma.

López C, Kleinheinz K, Aukema SM, Rohde M, Bernhart SH, Hübschmann D, Wagener R, Toprak UH, Raimondi F, Kreuz M, Waszak SM, Huang Z, Sieverling L, Paramasivam N, Seufert J, Sungalee S, Russell RB, Bausinger J, Kretzmer H, Ammerpohl O, Bergmann AK, Binder H, Borkhardt A, Brors B, Claviez A, Doose G, Feuerbach L, Haake A, Hansmann ML, Hoell J, Hummel M, Korbel JO, Lawerenz C, Lenze D, Radlwimmer B, Richter J, Rosenstiel P, Rosenwald A, Schilhabel MB, Stein H, Stilgenbauer S, Stadler PF, Szczepanowski M, Weniger MA, Zapatka M, Eils R, Lichter P, Loeffler M, Möller P, Trümper L, Klapper W; ICGC MMML-Seq Consortium, Hoffmann S, Küppers R, Burkhardt B, Schlesner M, Siebert R.

Nat Commun. 2019 Mar 29;10(1):1459. doi: 10.1038/s41467-019-08578-3.

2.

THROMBOTECT - a randomized study comparing low molecular weight heparin, antithrombin and unfractionated heparin for thromboprophylaxis during induction therapy of acute lymphoblastic leukemia in children and adolescents.

Greiner J, Schrappe M, Claviez A, Zimmermann M, Niemeyer C, Kolb R, Eberl W, Berthold F, Bergsträsser E, Gnekow A, Lassay E, Vorwerk P, Lauten M, Sauerbrey A, Rischewski J, Beilken A, Henze G, Korte W, Möricke A; THROMBOTECT Study Investigators.

Haematologica. 2019 Apr;104(4):756-765. doi: 10.3324/haematol.2018.194175. Epub 2018 Sep 27.

3.

Front-line imatinib treatment in children and adolescents with chronic myeloid leukemia: results from a phase III trial.

Suttorp M, Schulze P, Glauche I, Göhring G, von Neuhoff N, Metzler M, Sedlacek P, de Bont ESJM, Balduzzi A, Lausen B, Aleinikova O, Sufliarska S, Henze G, Strauss G, Eggert A, Kremens B, Groll AH, Berthold F, Klein C, Groß-Wieltsch U, Sykora KW, Borkhardt A, Kulozik AE, Schrappe M, Nowasz C, Krumbholz M, Tauer JT, Claviez A, Harbott J, Kreipe HH, Schlegelberger B, Thiede C.

Leukemia. 2018 Jul;32(7):1657-1669. doi: 10.1038/s41375-018-0179-9. Epub 2018 Jun 20.

PMID:
29925908
4.

"Mouse-MRD" in central nervous system acute lymphoblastic leukaemia: assessing bone marrow minimal residual disease using a xenograft model - from bedside to the bench and back again.

Alten J, Claviez A, Vieth S, Cario G, Schewe DM.

Br J Haematol. 2018 Nov;183(4):686-688. doi: 10.1111/bjh.15024. Epub 2017 Nov 28. No abstract available.

PMID:
29193025
5.

Pediatric prolactinoma: initial presentation, treatment, and long-term prognosis.

Hoffmann A, Adelmann S, Lohle K, Claviez A, Müller HL.

Eur J Pediatr. 2018 Jan;177(1):125-132. doi: 10.1007/s00431-017-3042-5. Epub 2017 Nov 22.

PMID:
29168011
6.

Diffuse high-grade gliomas with H3 K27M mutations carry a dismal prognosis independent of tumor location.

Karremann M, Gielen GH, Hoffmann M, Wiese M, Colditz N, Warmuth-Metz M, Bison B, Claviez A, van Vuurden DG, von Bueren AO, Gessi M, Kühnle I, Hans VH, Benesch M, Sturm D, Kortmann RD, Waha A, Pietsch T, Kramm CM.

Neuro Oncol. 2018 Jan 10;20(1):123-131. doi: 10.1093/neuonc/nox149.

7.

Alterations of microRNA and microRNA-regulated messenger RNA expression in germinal center B-cell lymphomas determined by integrative sequencing analysis.

Hezaveh K, Kloetgen A, Bernhart SH, Mahapatra KD, Lenze D, Richter J, Haake A, Bergmann AK, Brors B, Burkhardt B, Claviez A, Drexler HG, Eils R, Haas S, Hoffmann S, Karsch D, Klapper W, Kleinheinz K, Korbel J, Kretzmer H, Kreuz M, Küppers R, Lawerenz C, Leich E, Loeffler M, Mantovani-Loeffler L, López C, McHardy AC, Möller P, Rohde M, Rosenstiel P, Rosenwald A, Schilhabel M, Schlesner M, Scholz I, Stadler PF, Stilgenbauer S, Sungalee S, Szczepanowski M, Trümper L, Weniger MA, Siebert R, Borkhardt A, Hummel M, Hoell JI; ICGC MMML-Seq Project.

Haematologica. 2016 Nov;101(11):1380-1389. Epub 2016 Jul 6.

8.

[Unilateral upper eyelid membrane in conjunctivitis lignosa].

Bauer M, Koinzer S, Oschlies I, Claviez A, Tiede K, Roider J, Nölle B.

Ophthalmologe. 2016 Oct;113(10):878. German. No abstract available.

PMID:
27638173
9.

Pediatric Colorectal Carcinoma is Associated With Excellent Outcome in the Context of Cancer Predisposition Syndromes.

Weber ML, Schneider DT, Offenmüller S, Kaatsch P, Einsiedel HG, Benesch M, Claviez A, Ebinger M, Kramm C, Kratz C, Lawlor J, Leuschner I, Merkel S, Metzler M, Nustede R, Petsch S, Seeger KH, Schlegel PG, Suttorp M, Zolk O, Brecht IB.

Pediatr Blood Cancer. 2016 Apr;63(4):611-7. doi: 10.1002/pbc.25839. Epub 2015 Nov 17.

PMID:
26575411
10.

DNA methylome analysis in Burkitt and follicular lymphomas identifies differentially methylated regions linked to somatic mutation and transcriptional control.

Kretzmer H, Bernhart SH, Wang W, Haake A, Weniger MA, Bergmann AK, Betts MJ, Carrillo-de-Santa-Pau E, Doose G, Gutwein J, Richter J, Hovestadt V, Huang B, Rico D, Jühling F, Kolarova J, Lu Q, Otto C, Wagener R, Arnolds J, Burkhardt B, Claviez A, Drexler HG, Eberth S, Eils R, Flicek P, Haas S, Humme M, Karsch D, Kerstens HHD, Klapper W, Kreuz M, Lawerenz C, Lenzek D, Loeffler M, López C, MacLeod RAF, Martens JHA, Kulis M, Martín-Subero JI, Möller P, Nage I, Picelli S, Vater I, Rohde M, Rosenstiel P, Rosolowski M, Russell RB, Schilhabel M, Schlesner M, Stadler PF, Szczepanowski M, Trümper L, Stunnenberg HG, Küppers R, Ammerpohl O, Lichter P, Siebert R, Hoffmann S, Radlwimmer B.

Nat Genet. 2015 Nov;47(11):1316-1325. doi: 10.1038/ng.3413. Epub 2015 Oct 5.

11.

MINCR is a MYC-induced lncRNA able to modulate MYC's transcriptional network in Burkitt lymphoma cells.

Doose G, Haake A, Bernhart SH, López C, Duggimpudi S, Wojciech F, Bergmann AK, Borkhardt A, Burkhardt B, Claviez A, Dimitrova L, Haas S, Hoell JI, Hummel M, Karsch D, Klapper W, Kleo K, Kretzmer H, Kreuz M, Küppers R, Lawerenz C, Lenze D, Loeffler M, Mantovani-Löffler L, Möller P, Ott G, Richter J, Rohde M, Rosenstiel P, Rosenwald A, Schilhabel M, Schneider M, Scholz I, Stilgenbauer S, Stunnenberg HG, Szczepanowski M, Trümper L, Weniger MA; ICGC MMML-Seq Consortium, Hoffmann S, Siebert R, Iaccarino I.

Proc Natl Acad Sci U S A. 2015 Sep 22;112(38):E5261-70. doi: 10.1073/pnas.1505753112. Epub 2015 Sep 8.

12.

The PCBP1 gene encoding poly(rC) binding protein I is recurrently mutated in Burkitt lymphoma.

Wagener R, Aukema SM, Schlesner M, Haake A, Burkhardt B, Claviez A, Drexler HG, Hummel M, Kreuz M, Loeffler M, Rosolowski M, López C, Möller P, Richter J, Rohde M, Betts MJ, Russell RB, Bernhart SH, Hoffmann S, Rosenstiel P, Schilhabel M, Szczepanowski M, Trümper L, Klapper W, Siebert R; ICGC MMML-Seq-Project; "Molecular Mechanisms in Malignant Lymphomas" Network Project of the Deutsche Krebshilfe.

Genes Chromosomes Cancer. 2015 Sep;54(9):555-64. doi: 10.1002/gcc.22268. Epub 2015 Jul 14.

PMID:
26173642
13.

[Ligneous conjunctivitis].

Bauer M, Koinzer S, Oschlies I, Claviez A, Tiede K, Roider J, Nölle B.

Ophthalmologe. 2016 May;113(5):416-9. doi: 10.1007/s00347-015-0097-4. German.

PMID:
26142234
14.

Sequential karyotyping in Burkitt lymphoma reveals a linear clonal evolution with increase in karyotype complexity and a high frequency of recurrent secondary aberrations.

Aukema SM, Theil L, Rohde M, Bauer B, Bradtke J, Burkhardt B, Bonn BR, Claviez A, Gattenlöhner S, Makarova O, Nagel I, Oschlies I, Pott C, Szczepanowski M, Traulsen A, Kluin PM, Klapper W, Siebert R, Murga Penas EM.

Br J Haematol. 2015 Sep;170(6):814-25. doi: 10.1111/bjh.13501. Epub 2015 Jun 24.

PMID:
26104998
15.

Secondary histiocytic sarcoma may cause apparent persistence or recurrence of minimal residual disease in childhood acute lymphoblastic leukemia.

Alten J, Klapper W, Leuschner I, Eckert C, Beier R, Vallo E, Krause M, Claviez A, Vieth S, Bleckmann K, Möricke A, Schrappe M, Cario G.

Pediatr Blood Cancer. 2015 Sep;62(9):1656-60. doi: 10.1002/pbc.25523. Epub 2015 Apr 1. Review.

PMID:
25833113
16.

Ewing sarcoma of the posterior fossa in an adolescent girl.

Stark AM, Leuschner I, Mehdorn HM, Claviez A.

Case Rep Med. 2014;2014:439830. doi: 10.1155/2014/439830. Epub 2014 Dec 29.

17.

Recurrent RHOA mutations in pediatric Burkitt lymphoma treated according to the NHL-BFM protocols.

Rohde M, Richter J, Schlesner M, Betts MJ, Claviez A, Bonn BR, Zimmermann M, Damm-Welk C, Russell RB, Borkhardt A, Eils R, Hoell JI, Szczepanowski M, Oschlies I, Klapper W, Burkhardt B, Siebert R; German ICGC MMML-Seq-Project; NHL-BFM Study Group.

Genes Chromosomes Cancer. 2014 Nov;53(11):911-6. doi: 10.1002/gcc.22202. Epub 2014 Jul 8.

PMID:
25044415
18.

A recurrent 11q aberration pattern characterizes a subset of MYC-negative high-grade B-cell lymphomas resembling Burkitt lymphoma.

Salaverria I, Martin-Guerrero I, Wagener R, Kreuz M, Kohler CW, Richter J, Pienkowska-Grela B, Adam P, Burkhardt B, Claviez A, Damm-Welk C, Drexler HG, Hummel M, Jaffe ES, Küppers R, Lefebvre C, Lisfeld J, Löffler M, Macleod RA, Nagel I, Oschlies I, Rosolowski M, Russell RB, Rymkiewicz G, Schindler D, Schlesner M, Scholtysik R, Schwaenen C, Spang R, Szczepanowski M, Trümper L, Vater I, Wessendorf S, Klapper W, Siebert R; Molecular Mechanisms in Malignant Lymphoma Network Project; Berlin-Frankfurt-Münster Non-Hodgkin Lymphoma Group.

Blood. 2014 Feb 20;123(8):1187-98. doi: 10.1182/blood-2013-06-507996. Epub 2014 Jan 7.

19.

The impact of central review and central therapy planning on the treatment of children and adolescents with Hodgkin lymphoma.

Lüders H, Rühl U, Marciniak H, Haerting J, Claviez A, Mann G, Schellong G, Wickmann L, Dörffel W.

Eur J Cancer. 2014 Jan;50(2):425-33. doi: 10.1016/j.ejca.2013.09.017. Epub 2013 Oct 21.

PMID:
24157256
20.

Imatinib cessation in children and adolescents with chronic myeloid leukemia in chronic phase.

Millot F, Claviez A, Leverger G, Corbaciglu S, Groll AH, Suttorp M.

Pediatr Blood Cancer. 2014 Feb;61(2):355-7. doi: 10.1002/pbc.24521. Epub 2013 Sep 17.

PMID:
24106110
21.

Reply to A.S. Reese.

Dörffel W, Lüders H, Claviez A, Hasenclever D, Rühl U.

J Clin Oncol. 2013 Oct 1;31(28):3610-1. doi: 10.1200/JCO.2013.51.7656. Epub 2013 Sep 3. No abstract available.

PMID:
24002521
22.

Response of children with stage IV soft tissue sarcoma to topotecan and carboplatin: a phase II window trial of the cooperative soft tissue sarcoma group.

Bochennek K, Dantonello T, Koscielniak E, Claviez A, Dirksen U, Sauerbrey A, Beilken A, Klingebiel T.

Klin Padiatr. 2013 Nov;225(6):309-14. doi: 10.1055/s-0033-1341489. Epub 2013 Aug 14.

PMID:
23946091
23.

Treatment of Hodgkin's lymphoma in childhood and adolescence without radiotherapy.

Dörffel W, Claviez A, Lüders H, Rühl U.

Transl Pediatr. 2013 Jul;2(3):131-2. doi: 10.3978/j.issn.2224-4336.2013.07.02. No abstract available.

24.

Detection of irreversible changes in susceptibility-weighted images after whole-brain irradiation of children.

Peters S, Pahl R, Claviez A, Jansen O.

Neuroradiology. 2013 Jul;55(7):853-9. doi: 10.1007/s00234-013-1185-2. Epub 2013 Apr 16.

PMID:
23588615
25.

Treatment of children and adolescents with Hodgkin lymphoma without radiotherapy for patients in complete remission after chemotherapy: final results of the multinational trial GPOH-HD95.

Dörffel W, Rühl U, Lüders H, Claviez A, Albrecht M, Bökkerink J, Holte H, Karlen J, Mann G, Marciniak H, Niggli F, Schmiegelow K, Schwarze EW, Pötter R, Wickmann L, Schellong G.

J Clin Oncol. 2013 Apr 20;31(12):1562-8. doi: 10.1200/JCO.2012.45.3266. Epub 2013 Mar 18.

PMID:
23509321
26.

Primary intracranial soft tissue sarcoma in children and adolescents: a cooperative analysis of the European CWS and HIT study groups.

Benesch M, von Bueren AO, Dantonello T, von Hoff K, Pietsch T, Leuschner I, Claviez A, Bierbach U, Kropshofer G, Korinthenberg R, Graf N, Suttorp M, Kortmann RD, Friedrich C, von der Weid N, Kaatsch P, Klingebiel T, Koscielniak E, Rutkowski S.

J Neurooncol. 2013 Feb;111(3):337-45. doi: 10.1007/s11060-012-1020-3. Epub 2012 Dec 11.

PMID:
23229762
27.

Recurrent mutation of the ID3 gene in Burkitt lymphoma identified by integrated genome, exome and transcriptome sequencing.

Richter J, Schlesner M, Hoffmann S, Kreuz M, Leich E, Burkhardt B, Rosolowski M, Ammerpohl O, Wagener R, Bernhart SH, Lenze D, Szczepanowski M, Paulsen M, Lipinski S, Russell RB, Adam-Klages S, Apic G, Claviez A, Hasenclever D, Hovestadt V, Hornig N, Korbel JO, Kube D, Langenberger D, Lawerenz C, Lisfeld J, Meyer K, Picelli S, Pischimarov J, Radlwimmer B, Rausch T, Rohde M, Schilhabel M, Scholtysik R, Spang R, Trautmann H, Zenz T, Borkhardt A, Drexler HG, Möller P, MacLeod RA, Pott C, Schreiber S, Trümper L, Loeffler M, Stadler PF, Lichter P, Eils R, Küppers R, Hummel M, Klapper W, Rosenstiel P, Rosenwald A, Brors B, Siebert R; ICGC MMML-Seq Project.

Nat Genet. 2012 Dec;44(12):1316-20. doi: 10.1038/ng.2469. Epub 2012 Nov 11.

PMID:
23143595
28.

Extensive aneurysmal bone cyst of the mandible.

Möller B, Claviez A, Moritz JD, Leuschner I, Wiltfang J.

J Craniofac Surg. 2011 May;22(3):841-4. doi: 10.1097/SCS.0b013e31820f3703.

PMID:
21558939
29.

Malignant melanoma and Wiedemann-Beckwith syndrome in childhood.

Livingstone E, Caliebe A, Egberts F, Proksch E, Buiting K, Schubert C, Claviez A, Siebert R, Hauschild A.

Klin Padiatr. 2010 Nov;222(6):388-90. doi: 10.1055/s-0030-1267152. Epub 2010 Nov 5.

PMID:
21058226
30.

Therapy of steroid-refractory acute GVHD with CD52 antibody alemtuzumab is effective.

Schub N, Günther A, Schrauder A, Claviez A, Ehlert C, Gramatzki M, Repp R.

Bone Marrow Transplant. 2011 Jan;46(1):143-7. doi: 10.1038/bmt.2010.68. Epub 2010 Mar 29.

PMID:
20348971
31.

Perioperative intensity-modulated brachytherapy for refractory orbital rhabdomyosarcomas in children.

Strege RJ, Kovács G, Meyer JE, Holland D, Claviez A, Mehdorn MH; Interdisciplinary Group of Orbitazentrum UK S-H.

Strahlenther Onkol. 2009 Dec;185(12):789-98. doi: 10.1007/s00066-009-2012-x.

PMID:
20013088
32.

Allogeneic transplantation for children and adolescents with Hodgkin lymphoma.

Schmitz N, Sureda A, Dini G, Claviez A; Lymphoma and Pediatric Diseases Working Parties.

Blood. 2009 Nov 12;114(20):4605-6. doi: 10.1182/blood-2009-09-243766. No abstract available.

33.

Re-transplantation from the same unrelated donor in three adolescents with severe aplastic anemia after graft rejection.

Führer M, Claviez A, Klein B, Humpe A, Schrauder A.

Klin Padiatr. 2009 Nov-Dec;221(6):358-61. doi: 10.1055/s-0029-1239530. Epub 2009 Nov 4.

PMID:
19890787
34.

Allogeneic stem cell transplantation for pediatric and adolescent patients with CML: results from the prospective trial CML-paed I.

Suttorp M, Claviez A, Bader P, Peters C, Gadner H, Ebell W, Dilloo D, Kremens B, Kabisch H, Führer M, Zintl F, Göbel U, Klingebiel T.

Klin Padiatr. 2009 Nov-Dec;221(6):351-7. doi: 10.1055/s-0029-1239529. Epub 2009 Nov 4.

PMID:
19890786
35.

Rapid recovery of motor and cognitive functions after resection of a right frontal lobe meningioma in a child.

Carlsson G, Hufnagel M, Jansen O, Claviez A, Nabavi A.

Childs Nerv Syst. 2010 Jan;26(1):105-11. doi: 10.1007/s00381-009-0984-6. Epub 2009 Aug 29.

PMID:
19727763
36.

Allogeneic hematopoietic stem cell transplantation in children and adolescents with recurrent and refractory Hodgkin lymphoma: an analysis of the European Group for Blood and Marrow Transplantation.

Claviez A, Canals C, Dierickx D, Stein J, Badell I, Pession A, Mackinnon S, Slavin S, Dalle JH, Chacón MJ, Sarhan M, Wynn RF, Suttorp M, Dini G, Sureda A, Schmitz N; Lymphoma and Pediatric Diseases Working Parties.

Blood. 2009 Sep 3;114(10):2060-7. doi: 10.1182/blood-2008-11-189399. Epub 2009 Jun 4.

37.

Neurocutaneous melanosis: a fatal disease in early childhood.

Livingstone E, Claviez A, Spengler D, Barth H, Stark AM, Hugo HH, Hauschild A.

J Clin Oncol. 2009 May 1;27(13):2290-1. doi: 10.1200/JCO.2008.20.4388. Epub 2009 Apr 6. No abstract available.

PMID:
19349541
38.

Haematopoietic SCT for children and adolescents with relapsed and refractory Hodgkin's lymphoma.

Claviez A, Sureda A, Schmitz N.

Bone Marrow Transplant. 2008 Oct;42 Suppl 2:S16-24. doi: 10.1038/bmt.2008.278. Review.

PMID:
18978738
39.

Mesenchymal chondrosarcoma of soft tissues and bone in children, adolescents, and young adults: experiences of the CWS and COSS study groups.

Dantonello TM, Int-Veen C, Leuschner I, Schuck A, Furtwaengler R, Claviez A, Schneider DT, Klingebiel T, Bielack SS, Koscielniak E; CWS study group; COSS study group.

Cancer. 2008 Jun;112(11):2424-31. doi: 10.1002/cncr.23457.

40.

The NQO1 C609T polymorphism is associated with risk of secondary malignant neoplasms after treatment for childhood acute lymphoblastic leukemia: a matched-pair analysis from the ALL-BFM study group.

Stanulla M, Dynybil C, Bartels DB, Dördelmann M, Löning L, Claviez A, Schrappe M; ALL-BFM study group.

Haematologica. 2007 Nov;92(11):1581-2.

41.

t(6;14)(p22;q32): a new recurrent IGH@ translocation involving ID4 in B-cell precursor acute lymphoblastic leukemia (BCP-ALL).

Russell LJ, Akasaka T, Majid A, Sugimoto KJ, Loraine Karran E, Nagel I, Harder L, Claviez A, Gesk S, Moorman AV, Ross F, Mazzullo H, Strefford JC, Siebert R, Dyer MJ, Harrison CJ.

Blood. 2008 Jan 1;111(1):387-91. Epub 2007 Oct 16.

42.

Topotecan, cyclophosphamide, and etoposide (TCE) in the treatment of high-risk neuroblastoma. Results of a phase-II trial.

Simon T, Längler A, Harnischmacher U, Frühwald MC, Jorch N, Claviez A, Berthold F, Hero B.

J Cancer Res Clin Oncol. 2007 Sep;133(9):653-61. Epub 2007 May 4.

PMID:
17479288
43.

Congenital diffuse anaplastic astrocytoma with ependymal and leptomeningeal spread: case report.

Stark AM, Modlich S, Claviez A, van Baalen A, Hugo HH, Mehdorn HM.

J Neurooncol. 2007 Sep;84(3):325-8. Epub 2007 Apr 19. No abstract available.

PMID:
17443288
44.

Second allogeneic hematopoietic stem cell transplantation (HSCT) results in outcome similar to that of first HSCT for patients with juvenile myelomonocytic leukemia.

Yoshimi A, Mohamed M, Bierings M, Urban C, Korthof E, Zecca M, Sykora KW, Duffner U, Trebo M, Matthes-Martin S, Sedlacek P, Klingebiel T, Lang P, Führer M, Claviez A, Wössmann W, Pession A, Arvidson J, O'Marcaigh AS, van den Heuvel-Eibrink MM, Starý J, Hasle H, Nöllke P, Locatelli F, Niemeyer CM.

Leukemia. 2007 Mar;21(3):556-60. Epub 2007 Feb 1. No abstract available.

PMID:
17268527
45.

Chromosomal breakpoints affecting immunoglobulin loci are recurrent in Hodgkin and Reed-Sternberg cells of classical Hodgkin lymphoma.

Martín-Subero JI, Klapper W, Sotnikova A, Callet-Bauchu E, Harder L, Bastard C, Schmitz R, Grohmann S, Höppner J, Riemke J, Barth TF, Berger F, Bernd HW, Claviez A, Gesk S, Frank GA, Kaplanskaya IB, Möller P, Parwaresch RM, Rüdiger T, Stein H, Küppers R, Hansmann ML, Siebert R; Deutsche Krebshilfe Network Project Molecular Mechanisms in Malignant Lymphomas.

Cancer Res. 2006 Nov 1;66(21):10332-8.

46.

Characterization and expression of CT45 in Hodgkin's lymphoma.

Heidebrecht HJ, Claviez A, Kruse ML, Pollmann M, Buck F, Harder S, Tiemann M, Dörffel W, Parwaresch R.

Clin Cancer Res. 2006 Aug 15;12(16):4804-11.

47.

A 10-year-old girl with bifocal synovial sarcoma.

Weng WH, Claviez A, Krams M, Hashemi J, Larsson O, Larsson C, Suttorp M.

Lancet Oncol. 2006 Jul;7(7):605-7. No abstract available.

PMID:
16814213
48.

Diagnosis and management of cerebral salt wasting (CSW) in children: the role of atrial natriuretic peptide (ANP) and brain natriuretic peptide (BNP).

von Bismarck P, Ankermann T, Eggert P, Claviez A, Fritsch MJ, Krause MF.

Childs Nerv Syst. 2006 Oct;22(10):1275-81. Epub 2006 Apr 11.

PMID:
16607534
49.

Mesoblastic nephroma--a report from the Gesellschaft fur Pädiatrische Onkologie und Hämatologie (GPOH).

Furtwaengler R, Reinhard H, Leuschner I, Schenk JP, Goebel U, Claviez A, Kulozik A, Zoubek A, von Schweinitz D, Graf N; Gesellschaft fur Pädiatrische Onkologie und Hämatologie (GPOH) Nephroblastoma Study Group.

Cancer. 2006 May 15;106(10):2275-83.

50.

Rituximab plus chemotherapy in children with relapsed or refractory CD20-positive B-cell precursor acute lymphoblastic leukemia.

Claviez A, Eckert C, Seeger K, Schrauder A, Schrappe M, Henze G, von Stackelberg A.

Haematologica. 2006 Feb;91(2):272-3.

Supplemental Content

Loading ...
Support Center